Zhejiang Ausun Pharmaceutical Co Ltd (603229) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥121.49 Million ≈ $17.78 Million USD) by net assets (CN¥2.35 Billion ≈ $343.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Zhejiang Ausun Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Zhejiang Ausun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Zhejiang Ausun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Ausun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Ausun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Ausun Pharmaceutical Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shenzhen Riland Industry Co SHE:300154	0.062x
Swedish Logistic Property AB Series B ST:SLP-B	0.013x
Under Armour Inc A NYSE:UAA	0.194x
CH. Karnchang PCL BK:CK	0.046x
Cisen Pharmaceutical Co Ltd SHG:603367	0.049x
Orient Semiconductor Electronics Ltd TW:2329	0.023x
Douglas Dynamics Inc NYSE:PLOW	-0.082x
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	0.092x

Annual Cash Flow Conversion Efficiency for Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2025. View current stock price of Zhejiang Ausun Pharmaceutical Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.27 Billion ≈ $332.08 Million	CN¥156.51 Million ≈ $22.90 Million	0.069x	-11.94%
2024-12-31	CN¥2.27 Billion ≈ $332.45 Million	CN¥177.93 Million ≈ $26.04 Million	0.078x	-24.40%
2023-12-31	CN¥2.14 Billion ≈ $313.38 Million	CN¥221.85 Million ≈ $32.46 Million	0.104x	+25.54%
2022-12-31	CN¥1.46 Billion ≈ $213.81 Million	CN¥120.57 Million ≈ $17.64 Million	0.083x	-40.46%
2021-12-31	CN¥1.25 Billion ≈ $183.62 Million	CN¥173.90 Million ≈ $25.45 Million	0.139x	+12.78%
2020-12-31	CN¥1.13 Billion ≈ $164.90 Million	CN¥138.47 Million ≈ $20.26 Million	0.123x	-9.63%
2019-12-31	CN¥645.19 Million ≈ $94.41 Million	CN¥87.73 Million ≈ $12.84 Million	0.136x	+606.38%
2018-12-31	CN¥597.60 Million ≈ $87.45 Million	CN¥11.50 Million ≈ $1.68 Million	0.019x	-76.76%
2017-12-31	CN¥564.93 Million ≈ $82.67 Million	CN¥46.78 Million ≈ $6.85 Million	0.083x	-78.38%
2016-12-31	CN¥243.30 Million ≈ $35.60 Million	CN¥93.21 Million ≈ $13.64 Million	0.383x	+34.36%
2015-12-31	CN¥188.07 Million ≈ $27.52 Million	CN¥53.63 Million ≈ $7.85 Million	0.285x	+3.96%
2014-12-31	CN¥78.21 Million ≈ $11.44 Million	CN¥21.45 Million ≈ $3.14 Million	0.274x	-42.62%
2013-12-31	CN¥32.91 Million ≈ $4.82 Million	CN¥15.73 Million ≈ $2.30 Million	0.478x	+534.85%
2012-12-31	CN¥10.36 Million ≈ $1.52 Million	CN¥-1.14 Million ≈ $-166.57K	-0.110x	--

About Zhejiang Ausun Pharmaceutical Co Ltd

SHG:603229 China Biotechnology

Market Cap

$920.96 Million

CN¥6.29 Billion CNY

Market Cap Rank

#9323 Global

#2347 in China

Share Price

CN¥7.58

Change (1 day)

-0.26%

52-Week Range

CN¥7.27 - CN¥10.77

All Time High

CN¥1598.02